182. ESMO Awards - Episode 1

This week, we discuss neuroendocrine tumours and melanoma as our ESMO 25 journey continues. Trials for neuroendocrine cancers include HIF-2 alpha inhibitors, targeted alpha therapy, and a classic anti-PD-1/TIGIT bispecific antibody combined with standard etoposide and cisplatin c ...  Show more

For our third instalment of ESMO 2025, we explore lung cancer in all its glory, including small cell, mesothelioma and non-small cell lung cancer.Studies:DeLLphi-303SOHO-01ALBATROSPAULIENDREAM3ROptiTROP-Lung04For more episodes, resources and blog posts, visit www.inquisitiveonc.c ...  Show more

In this episode, Dr. Jessica Steier and Dr. Sarah Scheinman discuss the complexities of cancer with Dr. Joe Zundell, a cancer biologist. They explore the definition of cancer, its prevalence, and the hallmarks that characterize cancer cells. The conversation delves into the mecha ...  Show more

What really causes cancer? Will we ever find a cure? And why does our mistrust of medicine and obsession with big pharma conspiracies have such a grip on the way we think about it? In this episode, Jonathan Van Ness sits down with oncologist Dr. Stacy Wentworth to explore the big ...  Show more

This week, we round out our discussion on metastatic colorectal cancer, focusing on more targeted therapies for this disease. If you have not done so already, be sure to check out episode 107 for the first part of our metastatic colorectal cancer discussion.

Contents: </ ...

There’s a whirlwind of emotions that comes with a breast cancer diagnosis. But it doesn’t have to be a punishment.  Integrative Oncologist Dr. Jenn Simmons works as a breast cancer expert to help thousands of women see their breast cancer diagnosis as an opportunity to reclaim t ...  Show more